A self-assembling nanoparticle designed by a Univ. of Connecticut (UConn) professor is the key component of a potent new malaria vaccine that is showing promise in early tests. For years, scientists trying to develop a...
After 31 years of research, GlaxoSmithKline (GSK) has filed for regulatory approval for the first-ever malaria vaccine–which also happens to be the first vaccine developed against a parasite. The clinical trial...
Scientists undertaking a “Herculean study” in malaria parasite development recently announced that they are getting closer to disrupting the lifecycle of the parasite—one of the world’s deadliest diseases. Researchers...
Scientists seeking a vaccine against malaria, which kills a child every minute in Africa, have developed a promising new approach intended to imprison the disease-causing parasites inside the red blood cells they infect...
Most people kill a mosquito with a violent swat of the hand, but Yaroslav Tenzer is much more methodical — and tender. He needs the tiny pest’s body intact so he can harvest its salivary glands. Mosquito saliva is the...
A research team at the University of Geneva, Switzerland, published study results on Wednesday that revealed molecules toxic to Plasmodium falciparum but not human red blood cells, creating a way to combat malaria...
A form of malaria common in India, Southeast Asia and South America attacks human red blood cells by clamping down on the cells with a pair of proteins, new research at Washington University School of Medicine in St...
Researchers have found a way to use E. coli bacteria to inexpensively manufacture a once hard-to-produce protein that is critical to the development of a malaria vaccine. Nirbhay Kumar, professor and chair of tropical...
The study, led by Sheetij Dutta, from the Walter Reed Army Institute of Research, USA, and colleagues, focused on a protein called AMA1 needed by the Plasmodium falciparum parasite to invade blood cells and cause...
Oxford scientists have developed a novel new malaria vaccine which can protect against the deadly mosquito-borne disease. The vaccine has shown promising results in the first clinical trial to test whether it can...